Literature DB >> 19221666

The risk factors for ultrasound-diagnosed non-alcoholic fatty liver disease among adolescents.

Chen-Chung Fu1, Ming-Chen Chen, Yin-Ming Li, Tso-Tsai Liu, Li-Yu Wang.   

Abstract

INTRODUCTION: Non-alcoholic fatty liver disease (NAFLD) is garnering increasing interest and acceptance as one of the most important causes of chronic liver disease. The aim of this study was to investigate the risk factors for NAFLD among selected adolescent students in Hualien City, Taiwan.
MATERIALS AND METHODS: A stratified random sampling scheme was carried out among 1724 adolescent students aged 12 or 13 years old in Hualien City. In total, 220 students (normal: overweight: obese = 97:48:75) agreed to join the study. They underwent physical examination, laboratory tests and ultrasonography examination of the liver. Diagnosis of NAFLD in this study was based on sonographic evidence of a fatty liver and testing negative for serum HBsAg and anti- HCV antibody.
RESULTS: Of the 220 participants, 4 were excluded because they tested positive for HBsAg or anti-HCV antibody. NAFLD was detected in 86 (39.8%) out of the 216 subjects. The rate of NAFLD in the adolescents increased progressively from 16.0% in the normal group to 50.5% in the overweight group, and 63.5% among the obese subjects. Compared to their normal counterparts, adolescents with NAFLD had a significantly higher weight, body mass index (BMI), waist circumference, levels of alanine aminotransferase (ALT), triglyceride and nonhigh- density-lipoprotein (non-HDL) cholesterol. However, among the participants with NAFLD, only 20 (23.3%) showed ALT abnormality but there was an increasing trend of ALT abnormality as the severity of fatty liver increased. In addition, the higher ALT, Homeostasis model assessment- insulin resistance (HOMA-IR), cholesterol, triglyceride, and non-HDL levels and lower HDL-C as the severity of fatty liver increased. In a stepwise logistic regression analysis, the most significant factor associated with the presence of NAFLD was weight category. When compared with their normal counterparts, overweight and obese adolescents had a 4.14 and 5.98 times the risk of having NAFLD, respectively. Elevated ALT was the second most important factor as adolescents with elevated ALT were more likely to have NAFLD (odds ratio = 3.32, 95% CI: 1.16 to 9.50). Non-HDL cholesterol level was the third most important factor associated with NAFLD with a 3.81-fold increase in risk incurred for every l n (1 mg/dL) increment.
CONCLUSIONS: Obesity, ALT abnormality and elevated non-HDL-cholesterol are risk factors for NAFLD in adolescents. However, only 23.3% of the adolescents with NAFLD showed an abnormality for ALT. Therefore, ALT alone is not a sufficient indicator; and it is recommended that ultrasonography of the liver should be part of the routine health examination of obese adolescents.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19221666

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  11 in total

1.  Overview of screening methods for fatty liver disease in children.

Authors:  Caroline Anitha Devadason; Ann O Scheimann
Journal:  World J Hepatol       Date:  2012-01-27

2.  Coexistence of non-alcoholic fatty liver disease with elevated alanine aminotransferase is associated with insulin resistance in young Han males.

Authors:  Rui Wang; Qiang Lu; Ji Feng; Fuzai Yin; Chunmei Qin; Bo Liu; Yali Liu; Xiaoli Liu
Journal:  Endocrine       Date:  2011-07-28       Impact factor: 3.633

3.  Development of novel rat model for high-fat and high-cholesterol diet-induced steatohepatitis and severe fibrosis progression in SHRSP5/Dmcr.

Authors:  Kazuya Kitamori; Hisao Naito; Hazuki Tamada; Miya Kobayashi; Daisuke Miyazawa; Yuko Yasui; Kunihiro Sonoda; Satoru Tsuchikura; Naomi Yasui; Katsumi Ikeda; Takashi Moriya; Yukio Yamori; Tamie Nakajima
Journal:  Environ Health Prev Med       Date:  2011-08-19       Impact factor: 3.674

4.  Low docosahexaenoic acid content in plasma phospholipids is associated with increased non-alcoholic fatty liver disease in China.

Authors:  Ju-Sheng Zheng; Amei Xu; Tao Huang; Xiaomei Yu; Duo Li
Journal:  Lipids       Date:  2012-04-19       Impact factor: 1.880

5.  Gender difference of alanine aminotransferase elevation may be associated with higher hemoglobin levels among male adolescents.

Authors:  Solomon Chih-Cheng Chen; Jun-Jun Yeh; Mei-Hwei Chang; Yu-Kuei Liao; Li-Chen Hsiao; Choo-Aun Neoh; Teck-Siang Tok; Jung-Der Wang
Journal:  PLoS One       Date:  2010-10-12       Impact factor: 3.240

6.  Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Non-Obese Patients: A Population Study Using Proton-Magnetic Resonance Spectroscopy.

Authors:  Jeremy Lok Wei; Jonathan Chung-Fai Leung; Thomson Chi-Wang Loong; Grace Lai-Hung Wong; David Ka-Wai Yeung; Ruth Suk-Mei Chan; Henry Lik-Yuen Chan; Angel Mei-Ling Chim; Jean Woo; Winnie Chiu-Wing Chu; Vincent Wai-Sun Wong
Journal:  Am J Gastroenterol       Date:  2015-07-28       Impact factor: 10.864

7.  Obesity and air pollution: global risk factors for pediatric non-alcoholic fatty liver disease.

Authors:  Roya Kelishadi; Parinaz Poursafa
Journal:  Hepat Mon       Date:  2011-10       Impact factor: 0.660

8.  Association between elevated serum alanine aminotransferase and cardiometabolic risk factors in rural Chinese population: a cross-sectional study.

Authors:  Shuang Chen; Xiaofan Guo; Xingang Zhang; Shasha Yu; Hongmei Yang; Mohan Jiang; Guozhe Sun; Yingxian Sun
Journal:  BMC Cardiovasc Disord       Date:  2015-07-10       Impact factor: 2.298

9.  Prediction and Diagnosis of Non-Alcoholic Fatty Liver Disease (NAFLD) and Identification of Its Associated Factors Using the Classification Tree Method.

Authors:  Mehdi Birjandi; Seyyed Mohammad Taghi Ayatollahi; Saeedeh Pourahmad; Ali Reza Safarpour
Journal:  Iran Red Crescent Med J       Date:  2016-08-09       Impact factor: 0.611

Review 10.  Current therapies in alleviating liver disorders and cancers with a special focus on the potential of vitamin D.

Authors:  Shahida Khan; Ashraf Ali; Sarah Khan; Ahmed Bakillah; Ghazi Damanhouri; Aziz Khan; Ahmad Makki; Ibtehal AlAnsari; Naheed Banu
Journal:  Nutr Metab (Lond)       Date:  2018-02-09       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.